Israeli heart valve maker Mvalve reportedly pulls in a $15 million investment from Boston Scientific in a deal that includes a $200 million buyout option.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lNJuum
Cap comentari:
Publica un comentari a l'entrada